Diversification
for Research and experimental development on natural sciences and engineering (ISIC 7210)
Diversification is highly fitting for the R&D on natural sciences and engineering industry. The industry faces significant challenges related to 'Market Obsolescence & Substitution Risk' (MD01: score 2) and 'Funding Volatility & Competition' (MD03: score 2, IN05: score 4), which diversification...
Why This Strategy Applies
Entering a new product or market beyond a company's current activities to reduce risk and capture new revenue streams.
GTIAS pillars this strategy draws on — and this industry's average score per pillar
These pillar scores reflect Research and experimental development on natural sciences and engineering's structural characteristics. Higher scores indicate greater complexity or risk — see the full scorecard for all 81 attributes.
Diversification applied to this industry
Diversification is not merely a growth strategy but a critical resilience imperative for R&D on natural sciences and engineering, given high market obsolescence and R&D funding volatility. Proactive expansion into adjacent scientific fields and market applications, underpinned by strategic partnerships and robust IP leveraging, is essential to mitigate inherent risks and secure long-term capital and talent attraction.
Counter Market Obsolescence by Expanding Technology Horizons
The 'Market Obsolescence & Substitution Risk' (MD01: 2/5) is significant, meaning core R&D areas can quickly become outdated. Diversifying research into adjacent, yet distinct, technological pathways or application domains creates alternative value streams and builds resilience against rapid scientific advancements.
Allocate a dedicated fund (e.g., 15% of discretionary R&D budget) to explore and validate 2-3 alternative technology platforms that leverage existing scientific principles but target emerging, non-core market needs.
Access Broader Capital Pools through Portfolio Segmentation
The high 'R&D Burden & Innovation Tax' (IN05: 4/5) and challenging 'Price Formation Architecture' (MD03: 2/5) highlight intense competition for funding in core areas. Segmenting diversified R&D efforts allows access to varied funding sources, from public grants for foundational science to venture capital for disruptive commercial applications.
Develop distinct business cases and funding narratives for each diversification initiative, tailoring proposals to attract specific investor types (e.g., government agencies, corporate VCs, private equity) based on their risk appetite and strategic alignment.
Monetize Underutilized IP Across New Market Applications
R&D firms often possess specialized knowledge and intellectual property with latent potential beyond their original scope. Diversification provides a structured pathway to identify and exploit these assets in new market applications, increasing return on investment and mitigating 'Hedging Ineffectiveness' (FR07: 4/5) by creating new revenue options.
Institute an annual 'IP Re-evaluation Sprint' involving cross-functional teams (R&D, Legal, Business Development) to identify 3-5 existing patents or research findings with potential for licensing or spin-off ventures in non-core sectors.
Attract and Retain Talent with Diverse Project Opportunities
The 'Talent War & Attrition Risk' (MD07, as highlighted in existing analysis, reflecting competitive regime) is a persistent challenge in ISIC 7210. Diversified R&D portfolios offer researchers varied and challenging projects, fostering skill development, cross-pollination of ideas, and improved job satisfaction, which are crucial for retention.
Establish a formal program for inter-disciplinary project assignments, allowing high-potential researchers to dedicate 20-30% of their time to exploratory diversification initiatives, thereby enhancing skill sets and career progression.
Proactively Scout Emerging Scientific Frontiers for Growth
The high 'Innovation Option Value' (IN03: 4/5) emphasizes the potential of future discoveries, while high 'Hedging Ineffectiveness' (FR07: 4/5) stresses the risk of being unprepared for paradigm shifts. Proactive strategic foresight into emerging scientific fields ensures long-term relevance and secures early-mover advantages.
Form a dedicated 'Future Science Council' comprising senior researchers and external experts, tasked with monitoring and presenting quarterly assessments on 3-5 high-potential, emerging scientific domains for strategic investment consideration.
Strategic Overview
Diversification, in the context of Research and experimental development on natural sciences and engineering (ISIC 7210), involves expanding R&D efforts into new scientific fields, technologies, or market applications beyond a company's current core focus. This strategy is critical for mitigating the inherent risks of R&D, such as high investment risk in niche areas (MD01), market obsolescence due to rapid technological change (MD01), and the volatility of funding sources (MD03, IN05). By spreading research investments across multiple areas, organizations can reduce their dependence on the success of a single project or market segment, thereby enhancing resilience and long-term viability.
Furthermore, diversification allows R&D entities to leverage their core scientific and engineering competencies in novel ways, capturing new revenue streams and demonstrating broader ROI. For example, a firm specializing in materials science might apply its expertise from aerospace to biomedical devices, or a biotech firm could expand from pharmaceuticals into agricultural biotechnology. This strategic expansion helps address challenges related to demonstrating value and securing consistent funding by creating a more robust and adaptable portfolio of research initiatives and potential commercial applications. It also promotes the retention and development of diverse talent, fostering innovation through cross-pollination of ideas.
4 strategic insights for this industry
Risk Mitigation and Resilience Building
The high 'Market Obsolescence & Substitution Risk' (MD01) and 'Hedging Ineffectiveness & Carry Friction' (FR07) make single-focus R&D highly vulnerable. Diversification across multiple research domains or application areas spreads this risk, ensuring that the failure or obsolescence of one project does not jeopardize the entire organization, thereby building long-term resilience.
Leveraging Core Competencies and IP for Expanded Value
R&D firms possess specialized knowledge, infrastructure, and intellectual property. Diversification enables the application of existing core competencies and IP to adjacent fields or new market segments, improving the ability to 'Demonstrate ROI & Value' (MD03) and unlock new revenue streams from existing scientific assets. This can include licensing core technologies to new industries.
Stabilizing Funding and Enhancing Capital Attraction
With 'Funding Volatility & Competition' (MD03, IN05) being a significant challenge, diversified R&D portfolios can attract a broader range of funding sources, including government grants, venture capital for new sectors, and industry partnerships. A diversified portfolio presents a more stable and attractive investment profile, reducing dependence on single funding streams.
Talent Retention and Cross-Pollination of Ideas
Diversification provides researchers with opportunities to work on varied and challenging projects, addressing the 'Talent War & Attrition Risk' (MD07). It also encourages cross-disciplinary collaboration, leading to innovative solutions and the development of new expertise within the organization, fostering a more dynamic and attractive R&D environment.
Prioritized actions for this industry
Conduct regular strategic foresight exercises to identify emerging scientific fields and adjacent market applications where existing R&D capabilities can be effectively leveraged.
Proactive identification of complementary areas allows for planned expansion, reducing 'High Investment Risk in Niche Areas' and positioning the organization for future growth. This is crucial given the 'Rapid Obsolescence & High R&D Costs' (IN01).
Establish agile, cross-functional R&D units or special project teams specifically tasked with exploring and validating diversified opportunities, independent of core business pressures.
Dedicated teams with flexible mandates can accelerate exploration into new domains, managing the initial stages of diversification more effectively and allowing core R&D to remain focused. This helps overcome 'Prioritization & Focus Dilemma' (MD08).
Develop a structured, stage-gate investment framework for diversification initiatives, with clear evaluation criteria, milestones, and off-ramps to manage capital deployment and risk.
A phased approach ensures disciplined resource allocation and allows for early termination of unpromising ventures, mitigating 'High Investment Risk in Niche Areas' and 'Funding Volatility & Competition'.
Actively seek and forge strategic partnerships or joint ventures with organizations in target new sectors to gain market insights, share R&D costs, and accelerate commercialization.
Collaborations reduce financial burden and provide access to new distribution channels, market knowledge, and talent, addressing 'Funding Sustainability and Capital Scarcity' (IN05) and 'Limited Research Visibility & Impact' (MD06).
From quick wins to long-term transformation
- Conduct internal 'ideation sprints' or hackathons to identify potential new applications for existing technologies/expertise.
- Perform market analysis and competitive landscaping for 2-3 promising adjacent scientific fields.
- Allocate a small discretionary fund for pilot studies in low-cost, high-potential new areas.
- Establish formal strategic partnerships with academic institutions or startups in target diversification areas.
- Develop a specific budget line item for diversification R&D, independent of core project funding.
- Train existing R&D staff in new methodologies or interdisciplinary skills relevant to identified diversified areas.
- Acquire niche R&D firms or specialized intellectual property to rapidly enter new scientific domains.
- Restructure R&D departments to include dedicated 'exploration' or 'new ventures' divisions.
- Influence and shape emerging industry standards or regulatory frameworks in newly entered fields.
- Spreading resources too thinly across too many new ventures, leading to undercapitalization and poor outcomes.
- Lack of clear strategic alignment between diversified efforts and core competencies, resulting in disjointed R&D.
- Underestimating the distinct market dynamics, regulatory hurdles, or commercialization pipelines of new sectors.
- Cultural resistance within the organization to move beyond traditional research areas or accept new skill sets.
Measuring strategic progress
| Metric | Description | Target Benchmark |
|---|---|---|
| Percentage of R&D budget allocated to diversification projects | Measures the commitment to exploring new areas beyond the core focus. | 15-25% annually (varies by organization maturity and risk appetite) |
| Number of new scientific domains or market applications successfully entered | Quantifies the breadth of diversification efforts leading to tangible expansion. | 2-3 new domains/applications every 3-5 years |
| Revenue/Funding generated from diversified R&D projects as a percentage of total R&D funding | Indicates the financial viability and impact of diversification efforts. | 5-10% within 5 years of initiation, growing to 20%+ long-term |
| Number of cross-disciplinary patents or publications generated from diversification efforts | Reflects the innovation output and intellectual property expansion in new areas. | 10-15% of total IP annually linked to diversified fields |
Software to support this strategy
These tools are recommended across the strategic actions above. Each has been matched based on the attributes and challenges relevant to Research and experimental development on natural sciences and engineering.
Capsule CRM
10,000+ customers worldwide • Includes Transpond marketing platform
Transpond's email marketing and audience tools support proactive brand communication that builds customer loyalty and reduces churn-driven reputational fragility
Cost-effective CRM for growing teams — manage contacts, track deals and pipeline, build customer relationships, and streamline day-to-day work. Paired with Transpond, a dedicated marketing platform for email campaigns and audience management.
Try Capsule FreeAffiliate link — we may earn a commission at no cost to you.
HubSpot
Free forever plan • 288,700+ customers in 135+ countries
Deal intelligence, win/loss analytics, and pipeline data give sales teams the evidence to defend price with ROI proof rather than discounting reactively against commodity competition
All-in-one CRM and go-to-market platform used by 288,700+ businesses across 135+ countries. Connects marketing, sales, service, content, and operations in one system — free forever plan to start, paid tiers to scale.
Try HubSpot FreeAffiliate link — we may earn a commission at no cost to you.
Other strategy analyses for Research and experimental development on natural sciences and engineering
Also see: Diversification Framework